Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Screen on your Watchlists and Portfolios with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Masimo Corp (MASI)

Masimo Corp (MASI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 9,085,479
  • Shares Outstanding, K 54,219
  • Annual Sales, $ 2,094 M
  • Annual Income, $ -304,900 K
  • EBIT $ 82 M
  • EBITDA $ 187 M
  • 60-Month Beta 1.19
  • Price/Sales 4.44
  • Price/Cash Flow 26.23
  • Price/Book 9.60

Options Overview Details

View History
  • Implied Volatility 48.88% ( +5.40%)
  • Historical Volatility 29.97%
  • IV Percentile 77%
  • IV Rank 49.24%
  • IV High 69.93% on 04/07/25
  • IV Low 28.45% on 01/21/25
  • Put/Call Vol Ratio 1.83
  • Today's Volume 85
  • Volume Avg (30-Day) 56
  • Put/Call OI Ratio 0.32
  • Today's Open Interest 1,255
  • Open Int (30-Day) 1,055

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 8 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/25
See More
  • Average Estimate 1.23
  • Number of Estimates 5
  • High Estimate 1.30
  • Low Estimate 1.20
  • Prior Year 0.86
  • Growth Rate Est. (year over year) +43.02%

Price Performance

See More
Period Period Low Period High Performance
1-Month
157.54 +3.12%
on 06/13/25
174.50 -6.91%
on 06/10/25
-9.52 (-5.54%)
since 06/06/25
3-Month
135.81 +19.62%
on 04/09/25
174.50 -6.91%
on 06/10/25
+12.09 (+8.04%)
since 04/07/25
52-Week
101.61 +59.88%
on 08/05/24
194.88 -16.64%
on 03/03/25
+47.69 (+41.56%)
since 07/05/24

Most Recent Stories

More News
Masimo: Q1 Earnings Snapshot

Masimo: Q1 Earnings Snapshot

MASI : 162.45 (-3.06%)
Watch These 3 MedTech Stocks for Q1 Earnings: Beat or Miss?

The first-quarter 2025 earnings season is underway for the Medical sector (one of the 16 broad Zacks sectors within the Zacks Industry classification), with several MedTech companies already releasing...

MASI : 162.45 (-3.06%)
FMS : 27.95 (-0.60%)
CLOV : 2.89 (+12.89%)
GKOS Stock Falls Despite Q1 Earnings & Revenue Beat, Margins Decline

Glaukos Corporation GKOS reported first-quarter 2025 adjusted loss of 22 cents per share, which was narrower than the Zacks Consensus Estimate of a loss of 33 cents. The figure also improved from the...

MASI : 162.45 (-3.06%)
GKOS : 101.46 (-1.97%)
FMS : 27.95 (-0.60%)
AHCO : 9.25 (-0.75%)
ARAY Stock Down Despite Q3 Earnings Beat Estimates, Revenues Up Y/Y

Accuray Incorporated ARAY reported third-quarter fiscal 2025 loss per share of a cent compared with the year-ago period’s loss of 6 cents. The bottom line surpassed the Zacks Consensus Estimate by 80%.ARAY’s...

ARAY : 1.3400 (-5.63%)
MASI : 162.45 (-3.06%)
FMS : 27.95 (-0.60%)
AHCO : 9.25 (-0.75%)
CNMD Stock Up On Q1 Earnings & Sales Beat, Raised 2025 Outlook

CONMED Corporation CNMD delivered first-quarter 2025 adjusted earnings per share (EPS) of 95 cents, which beat the Zacks Consensus Estimate of 81 cents by 17.3%. The bottom line improved 20.3% from the...

MASI : 162.45 (-3.06%)
CNMD : 51.93 (-4.42%)
FMS : 27.95 (-0.60%)
AHCO : 9.25 (-0.75%)
Why You Shouldn't Bet Against Masimo (MASI) Stock

One stock that might be an intriguing choice for investors right now is Masimo Corporation MASI. This is because this security in the Medical - Instruments space is seeing solid earnings estimate revision...

MASI : 162.45 (-3.06%)
3 Healthcare Stocks Facing Headwinds

3 Healthcare Stocks Facing Headwinds

STE : 233.32 (-1.78%)
LMAT : 82.98 (-1.67%)
MASI : 162.45 (-3.06%)
Q4 Patient Monitoring Earnings Review: First Prize Goes to Masimo (NASDAQ:MASI)

Q4 Patient Monitoring Earnings Review: First Prize Goes to Masimo (NASDAQ:MASI)

RMD : 256.41 (-0.21%)
MASI : 162.45 (-3.06%)
PODD : 300.70 (-0.12%)
IRTC : 139.22 (-2.28%)
DXCM : 82.94 (+0.01%)
Q4 Earnings Highlights: iRhythm (NASDAQ:IRTC) Vs The Rest Of The Patient Monitoring Stocks

Q4 Earnings Highlights: iRhythm (NASDAQ:IRTC) Vs The Rest Of The Patient Monitoring Stocks

RMD : 256.41 (-0.21%)
MASI : 162.45 (-3.06%)
IRTC : 139.22 (-2.28%)
PODD : 300.70 (-0.12%)
DXCM : 82.94 (+0.01%)
Patient Monitoring Stocks Q4 In Review: Insulet (NASDAQ:PODD) Vs Peers

Patient Monitoring Stocks Q4 In Review: Insulet (NASDAQ:PODD) Vs Peers

RMD : 256.41 (-0.21%)
MASI : 162.45 (-3.06%)
PODD : 300.70 (-0.12%)
IRTC : 139.22 (-2.28%)
DXCM : 82.94 (+0.01%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 24% Buy with a Weakest short term outlook on maintaining the current direction.

See More Share

Business Summary

Masimo Corporation develops, manufactures and markets a family of non-invasive monitoring systems. The Company has two segments: Product Revenues, Royalty & Other revenues. Within Product revenues, the company's flagship - Signal Extraction Tecgnology (SET) Pulse Oximetry - is used to monitor blood oxygen...

See More

Key Turning Points

3rd Resistance Point 172.35
2nd Resistance Point 170.14
1st Resistance Point 166.30
Last Price 162.45
1st Support Level 160.24
2nd Support Level 158.03
3rd Support Level 154.19

See More

52-Week High 194.88
Last Price 162.45
Fibonacci 61.8% 159.25
Fibonacci 50% 148.24
Fibonacci 38.2% 137.24
52-Week Low 101.61

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar